Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Tech Coloproctol ; 17(5): 497-500, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23471541

RESUMEN

BACKGROUND: Thromboembolic complications have been reported in patients with Crohn's disease. Among the contributing factors, hyperhomocysteinemia has been described, although controversial data exist. The aim of our study was to assess the incidence of hyperhomocysteinemia in a nonselected group of patients with Crohn's disease and to determine whether it might represent a risk marker for thrombosis in such patients. METHODS: Fifty consecutive patients were recruited, and clinical and laboratory variables were compared between those without and those with hyperhomocysteinemia. In the latter, gene mutations in N5-N10-methyltetrahydrofolate reductase were searched for, and clinical and laboratory variables were related to hyperhomocysteinemia. The presence/absence of thrombotic episodes in both groups was determined. RESULTS: Both groups had similar clinically active disease, with higher C-reactive protein values found in those with hyperhomocysteinemia. Hyperhomocysteinemia was found in 46 % of patients. Of these, 74 % had moderate, 13 % intermediate, and 13 % severe increase in serum homocysteine levels. No relationship was found between homocysteine levels, and age, vitamin B12 levels, folic acid levels, Crohn's Disease Activity Index score, and CRP values. Gene mutations were found in 5 (22 %) patients, 2 homozygotes and 3 heterozygotes. None of the patients with or without hyperhomocysteinemia had episodes of venous or arterial thrombosis, or stroke. CONCLUSIONS: Hyperhomocysteinemia is frequent in patients with Crohn's disease, and it could be a cofactor for the pathogenesis of thrombotic episodes.


Asunto(s)
Enfermedad de Crohn/epidemiología , Hiperhomocisteinemia/epidemiología , Tromboembolia/epidemiología , Adulto , Distribución por Edad , Proteína C-Reactiva/metabolismo , Estudios de Cohortes , Comorbilidad , Enfermedad de Crohn/diagnóstico , Enfermedad de Crohn/terapia , Femenino , Humanos , Hiperhomocisteinemia/diagnóstico , Hiperhomocisteinemia/terapia , Masculino , Persona de Mediana Edad , Prevalencia , Pronóstico , Medición de Riesgo , Índice de Severidad de la Enfermedad , Distribución por Sexo , Análisis de Supervivencia , Tromboembolia/diagnóstico , Tromboembolia/terapia , Adulto Joven
2.
Rev Esp Enferm Dig ; 102(9): 538-41, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20883070

RESUMEN

BACKGROUND: to date, there are few data on colonoscopic findings in patients with celiac disease, and most of these obtained in patients with iron deficiency anaemia. AIMS: we assessed colonoscopic findings in unselected patients with coeliac disease, since there are no studies available also considering morphological aspects, and there is literature suggestion of increased prevalence of colorectal tumours. MATERIAL AND METHODS: colonoscopies with multiple biopsies were retrospectively analyzed in 42 coeliac disease patients on gluten-free diet above age 40; 16 had clinical or laboratory features of iron deficiency anaemia. Mucosal biopsies were evaluated for the presence of intraepithelial lymphocytes and of mucosal eosinophils, in addition to conventional histologic assessment, and compared with those obtained in 15 controls. RESULTS: macroscopic abnormalities (polyps, diverticula, inflammatory changes) were found in 26% of patients. Microscopic abnormalities (lymphocytic colitis, melanosis coli, rectal histiocytosis) were found in 36% of patients. None of these findings was found in controls. Coeliac disease patients had significantly higher eosinophil score than controls in the right colon, whereas this was not significantly different between groups in the left colon. CONCLUSIONS: colonoscopic findings in coeliac disease on gluten-free diet may reveal significant findings, even in patients without iron deficiency anaemia. There is the need of further studies in larger cohorts of patients to establish whether colonoscopy in these patients may be clinically useful.


Asunto(s)
Enfermedad Celíaca/dietoterapia , Enfermedad Celíaca/patología , Colonoscopía , Dieta Sin Gluten , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
3.
Aliment Pharmacol Ther ; 29(5): 535-41, 2009 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-19077107

RESUMEN

BACKGROUND: The colon shows frequent eosinophilic infiltration in allergic proctocolitis of infants, whereas in adults, eosinophilic infiltration of the colon is less defined and may be found in different conditions including drug-induced colitis, even though the pathological findings are often inconsistent. AIM: To quantify eosinophils in the mucosa of normal controls and to compare them with those of patients with abdominal symptoms related to 'drug colitis'. METHODS: Mucosal biopsies were obtained during colonoscopy in 15 controls and in 27 patients with abdominal symptoms, a history of probable 'drug-related colitis' and without obvious causes of eosinophilia. RESULTS: The drugs related to the patient symptoms were nonsteroidal anti-inflammatory drugs (70%), antiplatelet agents (19%) and oestroprogestinic agents (11%). Colonoscopy was normal in 30% of patients and abnormal in 70%. Histology showed low content of inflammatory cells and normal crypt architecture in-patients with endoscopy similar to inflammatory bowel diseases. The eosinophil score was significantly higher in the left side of the colon in the patient group compared with controls. CONCLUSIONS: The finding of an increased eosinophil count limited to the left (descending and sigmoid) colon is an important clue towards a diagnosis of drug-related colitis.


Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Colitis/inducido químicamente , Colon/efectos de los fármacos , Eosinófilos/patología , Inhibidores de Agregación Plaquetaria/efectos adversos , Progestinas/efectos adversos , Adulto , Anciano , Anciano de 80 o más Años , Biopsia , Estudios de Casos y Controles , Colitis/patología , Femenino , Humanos , Mucosa Intestinal/patología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Estadística como Asunto
4.
J Endocrinol Invest ; 28(2): 102-5, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15887853

RESUMEN

Sex steroid hormones contribute to the physiological regulation of bone turnover in males. To address this issue, we investigated serum estradiol (E2), total testosterone (T), and DHEAS concentrations, along with serum levels of carboxy-terminal telopeptide of type I collagen (sCTx), in a sample of 76 healthy men aged 23 to 87. The concentration of sCTx declined with age. Both T and DHEAS, at variance with E2, showed a significant age-related decline. T, DHEAS and sCTx significantly (p<0.01) correlated with each other. DHEAS and T were significantly associated after correcting for age (r=0.35, p=0.002) or body mass index (r=0.65, p<0.0001). DHEAS, but not T, significantly correlated with sCTx after correcting for age (r=0.26, p=0.026, and r=0.20, p=0.08, respectively). Stepwise multiple regression analysis showed that only DHEAS (but not T or E2) was a significant independent predictor of sCTx (p=0.0001). Our results show that adrenal androgens play a crucial role in regulating bone resorption in aging men.


Asunto(s)
Remodelación Ósea , Colágeno/sangre , Sulfato de Deshidroepiandrosterona/sangre , Péptidos/sangre , Adulto , Anciano , Anciano de 80 o más Años , Envejecimiento/sangre , Índice de Masa Corporal , Colágeno Tipo I , Estradiol/sangre , Humanos , Masculino , Persona de Mediana Edad , Valores de Referencia , Testosterona/sangre
5.
G Chir ; 26(11-12): 415-8, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16472418

RESUMEN

A 81-year old woman affected by chronic renal failure, non insulin-dependent diabetes mellitus (NIDM) and hypertension, had an severe anemia massive hematochezia. The colonoscopy could not localize the bleeding site except some blood spots in the rectum. The patient was readmitted after 1 month with hypovolemic shock by massive hematochezia and required several blood transfusions. The endoscopic examination showed an important arterial bleeding treated successfully with epinephrine and bipolar elettro-coagulation (BICAP). We suggested that the patient presented a Dieulafoy-like lesion; this is an uncommon gastrointestinal cause of bleeding due to a defect of a submucosal artery without evidence of atherosclerosis or vasculitis. Both chronic renal failure and age could be considered as predisponent factors in this patient. Hematochezia is the most important sign and is often complicated by haemorrhagic shock. The diagnosis was delayed due to the difficulty in localizing the bleeding site; moreover, the patient needed several blood transfusions. The arteriographic diagnosis associated to endoscopic treatment by epinephrine and BICAP enabled a successful therapy.


Asunto(s)
Endoscopía , Hemorragia Gastrointestinal/terapia , Mucosa Intestinal/anomalías , Enfermedades del Recto/terapia , Agonistas Adrenérgicos/uso terapéutico , Factores de Edad , Anciano , Anciano de 80 o más Años , Angiografía , Transfusión Sanguínea , Electrocoagulación , Epinefrina/uso terapéutico , Femenino , Estudios de Seguimiento , Hemorragia Gastrointestinal/etiología , Hemorragia Gastrointestinal/cirugía , Humanos , Mucosa Intestinal/irrigación sanguínea , Enfermedades del Recto/diagnóstico por imagen , Enfermedades del Recto/etiología , Enfermedades del Recto/cirugía , Factores de Riesgo , Choque Hemorrágico/etiología , Choque Hemorrágico/terapia , Factores de Tiempo , Resultado del Tratamiento
6.
J Endocrinol Invest ; 28(10 Suppl): 69-72, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16550727

RESUMEN

Cardiovascular disease (CVD) and osteoporosis (OP) are public health problems with numerous epidemiological links and important economic consequences. Recent studies have demonstrated that CVD and cardiovascular mortality are associated with reduced bone mineral density (BMD) and bone fractures. These two conditions may be sustained by similar or common pathophysiological mechanisms and risk factors. There are several matrix proteins, such as type 1 collagen, proteoglycan, osteopontin, and osteonectin, which are found in bone and vascular matrix components. Matrix proteins play an important role both in bone formation and in the development of atherosclerosis. Estrogens also play a role in both CVD and OP through their effects on cytokines, such as IL-1, IL-6 and TNF-alpha and osteoprotegerin (OPG). The lack of estrogens induces an increase in these cytokines and a decrease in OPG, both implicated in the mechanisms of bone loss and atherogenesis. An additional link between CVD and OP seems to be related to the action of some drugs, such as bisphosphonates, statins and raloxifene. Several studies suggest that the mechanism of action of these drugs at cellular level may not be mutually exclusive, acting either in bone or in atherosclerotic plaque. However, further studies are necessary to define the relationship between CVD and OP more specifically and to understand the complex interaction of similar or common risk factors and genetic or molecular determinants.


Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/fisiopatología , Osteoporosis Posmenopáusica/fisiopatología , Osteoporosis/fisiopatología , Aterosclerosis/epidemiología , Aterosclerosis/etiología , Aterosclerosis/fisiopatología , Densidad Ósea/efectos de los fármacos , Conservadores de la Densidad Ósea/uso terapéutico , Enfermedades Cardiovasculares/tratamiento farmacológico , Enfermedades Cardiovasculares/genética , Colesterol/biosíntesis , Difosfonatos/farmacología , Difosfonatos/uso terapéutico , Estrógenos/fisiología , Proteínas de la Matriz Extracelular/fisiología , Femenino , Fracturas Óseas/epidemiología , Fracturas Óseas/fisiopatología , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacología , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Masculino , Osteogénesis/efectos de los fármacos , Osteoporosis/tratamiento farmacológico , Osteoporosis/epidemiología , Osteoporosis/genética , Osteoporosis Posmenopáusica/tratamiento farmacológico , Osteoporosis Posmenopáusica/epidemiología , Osteoporosis Posmenopáusica/genética , Factores de Riesgo
7.
Dis Esophagus ; 16(3): 270-2, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14641325

RESUMEN

We present a case of systemic Hodgkin's lymphoma, relapsed with esophageal involvement after 3 years of complete remission. The importance of an accurate diagnostic work-up is emphasized. Esophagectomy and chemotherapy followed by bone marrow transplantation allowed a complete response and the long-term survival of the patient.


Asunto(s)
Neoplasias Esofágicas/cirugía , Enfermedad de Hodgkin/cirugía , Adulto , Humanos , Masculino , Recurrencia
8.
Bone Marrow Transplant ; 32(2): 231-6, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12838290

RESUMEN

We retrospectively analyzed red blood cell (RBC) support and alloimmunization rate in 218 consecutive patients - 128 from the Pediatric Department and 90 from the adult Hematology Department - undergoing hematopoietic stem cell transplantation (HSCT) between 1994 and 2000. In the pre-HSCT period, the pediatric patients undergoing auto-HSCT required more RBC support. In the post-HSCT period, pediatric patients transplanted with an unrelated donor required more RBC support (median 13.5 U/10 kg bw) than patients receiving HSCT from a related donor (median 6 U/10 kg bw) or from an autologous source (median 4 U/10 kg bw, P=0.0004). In the pre-HSCT period, 159 out of 218 patients (73%) received a total of 1843 RBC units, with an overall median of 9 U/patient over a median of 24 months (range 4-62); 10 patients (6%) developed a total of 12 alloantibodies, with an alloimmunization rate of 5.4/1000 RBC units. In the post-HSCT period, all but three patients were given a total of 2420 RBC units, with an overall median of 6 U/patient over a median of 4 months (range 1-18); all but one of the pre-existing alloantibodies disappeared and three patients (1%) developed new alloantibodies with an alloimmunization rate of 1.2/1000 RBC units. These newly produced alloantibodies (one anti-M and two anti-E) were detected at +58, +90 and +210 days after HSCT. These findings might suggest a different approach to alloantibody screening tests in patients receiving HSCT, with a subsequent reduction of costs and laboratory workload.


Asunto(s)
Formación de Anticuerpos , Transfusión de Eritrocitos/estadística & datos numéricos , Eritrocitos/inmunología , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Isoanticuerpos , Adolescente , Adulto , Anciano , Antígenos de Grupos Sanguíneos , Niño , Preescolar , Femenino , Neoplasias Hematológicas/terapia , Humanos , Lactante , Isoantígenos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
9.
Dis Esophagus ; 14(2): 166-8, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11553231

RESUMEN

Black esophagus is a rare condition, reported for the first time in 1990. It is always noted in severely compromised patients. The diagnosis is possible using endoscopy. An esophageal ischemic injury should be considered. It is important that a differential diagnosis is made with consideration of other necrotic conditions of the esophagus. Only supportive treatment and the improvement of the associated disease appear possible.


Asunto(s)
Enfermedades del Esófago/patología , Anciano , Antiulcerosos/administración & dosificación , Diagnóstico Diferencial , Endoscopía Gastrointestinal , Enfermedades del Esófago/complicaciones , Enfermedades del Esófago/terapia , Resultado Fatal , Humanos , Masculino , Necrosis , Pronóstico
10.
J Clin Ultrasound ; 29(6): 354-8, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11424102

RESUMEN

Cutaneous seeding is a rare complication of interventional ultrasound procedures. We describe a case of needle-track cutaneous seeding of hepatocellular carcinoma (HCC) after sonographically guided percutaneous ethanol injection (PEI). In our case, the seeding might have been related to the type of needle used and the multiple passes required to treat the liver lesion. Despite the risk of needle-track seeding, PEI remains useful in the treatment of HCC.


Asunto(s)
Carcinoma Hepatocelular/secundario , Etanol/administración & dosificación , Neoplasias Hepáticas/tratamiento farmacológico , Siembra Neoplásica , Neoplasias Cutáneas/secundario , Ultrasonografía Intervencional/efectos adversos , Anciano , Anciano de 80 o más Años , Carcinoma Hepatocelular/tratamiento farmacológico , Etanol/uso terapéutico , Humanos , Inyecciones Subcutáneas , Neoplasias Hepáticas/patología , Masculino
11.
Anticancer Res ; 21(2B): 1499-502, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11396239
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA